世界のインフルエンザワクチン市場2020-2025:全ウイルスワクチン、分割ウイルスワクチン、サブユニットワクチン、弱毒生ウイルスワクチン

LP Informationが発行した調査報告書(LPI20DE2035)
◆英語タイトル:Global Influenza Vaccine Market Growth 2020-2025
◆商品コード:LPI20DE2035
◆発行会社(リサーチ会社):LP Information
◆発行日:2020年12月(※2024年版があります。お問い合わせください。)
◆ページ数:130
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

「インフルエンザワクチンの世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、全ウイルスワクチン、分割ウイルスワクチン、サブユニットワクチン、弱毒生ウイルスワクチンなど、用途別には、子供(6ヶ月-3歳)、大人・3歳以上の子供などに区分してまとめた調査レポートです。インフルエンザワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・インフルエンザワクチンの世界市場概要(サマリー)
・インフルエンザワクチンの企業別販売量・売上
・インフルエンザワクチンの企業別市場シェア
・インフルエンザワクチンの世界市場規模 2015年-2020年:種類別(全ウイルスワクチン、分割ウイルスワクチン、サブユニットワクチン、弱毒生ウイルスワクチン)
・インフルエンザワクチンの世界市場規模 2015年-2020年:用途別(子供(6ヶ月-3歳)、大人・3歳以上の子供)
・インフルエンザワクチンの米州市場規模(アメリカ、カナダ、メキシコなど)
・インフルエンザワクチンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・インフルエンザワクチンの欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・インフルエンザワクチンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・インフルエンザワクチン市場の成長要因・課題・動向
・インフルエンザワクチンの世界市場予測 2021年-2025年
・インフルエンザワクチンの米州市場予測(アメリカ、カナダ、メキシコなど)
・インフルエンザワクチンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・インフルエンザワクチンの欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・インフルエンザワクチンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・インフルエンザワクチンの世界市場予測:種類別(全ウイルスワクチン、分割ウイルスワクチン、サブユニットワクチン、弱毒生ウイルスワクチン)
・インフルエンザワクチンの世界市場予測:用途別(子供(6ヶ月-3歳)、大人・3歳以上の子供)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Influenza Vaccine market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Influenza Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Vaccine market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Influenza Vaccine, covering the supply chain analysis, impact assessment to the Influenza Vaccine market size growth rate in several scenarios, and the measures to be undertaken by Influenza Vaccine companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
For Children (6 months to 3 years)
For Adults and Children over 3 years

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CSL
GSK
Mylan
AstraZeneca
Sanofi Pasteur
Pfizer
Johnson & Johnson

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Influenza Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Influenza Vaccine market by identifying its various subsegments.
Focuses on the key global Influenza Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Influenza Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Influenza Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Influenza Vaccine Consumption 2015-2025
2.1.2 Influenza Vaccine Consumption CAGR by Region
2.2 Influenza Vaccine Segment by Type
2.2.1 Whole Virus Vaccines
2.2.2 Split Virus Vaccines
2.2.3 Subunit Vaccines
2.2.4 Live Attenuated Virus Vaccines
2.3 Influenza Vaccine Consumption by Type
2.3.1 Global Influenza Vaccine Consumption Market Share by Type (2015-2020)
2.3.2 Global Influenza Vaccine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Influenza Vaccine Sale Price by Type (2015-2020)
2.4 Influenza Vaccine Segment by Application
2.4.1 For Children (6 months to 3 years)
2.4.2 For Adults and Children over 3 years
2.5 Influenza Vaccine Consumption by Application
2.5.1 Global Influenza Vaccine Consumption Market Share by Type (2015-2020)
2.5.2 Global Influenza Vaccine Value and Market Share by Type (2015-2020)
2.5.3 Global Influenza Vaccine Sale Price by Type (2015-2020)

3 Global Influenza Vaccine by Company
3.1 Global Influenza Vaccine Sales Market Share by Company
3.1.1 Global Influenza Vaccine Sales by Company (2018-2020)
3.1.2 Global Influenza Vaccine Sales Market Share by Company (2018-2020)
3.2 Global Influenza Vaccine Revenue Market Share by Company
3.2.1 Global Influenza Vaccine Revenue by Company (2018-2020)
3.2.2 Global Influenza Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global Influenza Vaccine Sale Price by Company
3.4 Global Influenza Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Influenza Vaccine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Influenza Vaccine by Regions
4.1 Influenza Vaccine by Regions
4.2 Americas Influenza Vaccine Consumption Growth
4.3 APAC Influenza Vaccine Consumption Growth
4.4 Europe Influenza Vaccine Consumption Growth
4.5 Middle East & Africa Influenza Vaccine Consumption Growth

5 Americas
5.1 Americas Influenza Vaccine Consumption by Countries
5.1.1 Americas Influenza Vaccine Consumption by Countries (2015-2020)
5.1.2 Americas Influenza Vaccine Value by Countries (2015-2020)
5.2 Americas Influenza Vaccine Consumption by Type
5.3 Americas Influenza Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Influenza Vaccine Consumption by Regions
6.1.1 APAC Influenza Vaccine Consumption by Regions (2015-2020)
6.1.2 APAC Influenza Vaccine Value by Regions (2015-2020)
6.2 APAC Influenza Vaccine Consumption by Type
6.3 APAC Influenza Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Influenza Vaccine by Countries
7.1.1 Europe Influenza Vaccine Consumption by Countries (2015-2020)
7.1.2 Europe Influenza Vaccine Value by Countries (2015-2020)
7.2 Europe Influenza Vaccine Consumption by Type
7.3 Europe Influenza Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Influenza Vaccine by Countries
8.1.1 Middle East & Africa Influenza Vaccine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Influenza Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa Influenza Vaccine Consumption by Type
8.3 Middle East & Africa Influenza Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Influenza Vaccine Distributors
10.3 Influenza Vaccine Customer

11 Global Influenza Vaccine Market Forecast
11.1 Global Influenza Vaccine Consumption Forecast (2021-2025)
11.2 Global Influenza Vaccine Forecast by Regions
11.2.1 Global Influenza Vaccine Forecast by Regions (2021-2025)
11.2.2 Global Influenza Vaccine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Influenza Vaccine Forecast by Type
11.8 Global Influenza Vaccine Forecast by Application

12 Key Players Analysis
12.1 CSL
12.1.1 Company Information
12.1.2 Influenza Vaccine Product Offered
12.1.3 CSL Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 CSL Latest Developments
12.2 GSK
12.2.1 Company Information
12.2.2 Influenza Vaccine Product Offered
12.2.3 GSK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 GSK Latest Developments
12.3 Mylan
12.3.1 Company Information
12.3.2 Influenza Vaccine Product Offered
12.3.3 Mylan Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Mylan Latest Developments
12.4 AstraZeneca
12.4.1 Company Information
12.4.2 Influenza Vaccine Product Offered
12.4.3 AstraZeneca Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 AstraZeneca Latest Developments
12.5 Sanofi Pasteur
12.5.1 Company Information
12.5.2 Influenza Vaccine Product Offered
12.5.3 Sanofi Pasteur Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Sanofi Pasteur Latest Developments
12.6 Pfizer
12.6.1 Company Information
12.6.2 Influenza Vaccine Product Offered
12.6.3 Pfizer Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Pfizer Latest Developments
12.7 Johnson & Johnson
12.7.1 Company Information
12.7.2 Influenza Vaccine Product Offered
12.7.3 Johnson & Johnson Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Johnson & Johnson Latest Developments

13 Research Findings and Conclusion



【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のインフルエンザワクチン市場2020-2025:全ウイルスワクチン、分割ウイルスワクチン、サブユニットワクチン、弱毒生ウイルスワクチン(Global Influenza Vaccine Market Growth 2020-2025)]についてメールでお問い合わせはこちらでお願いします。